Quality Indicators for the Management of Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma: International Consensus Recommendations from the American Gastroenterological Association Symposium

Prateek Sharma, David A. Katzka, Neil Gupta, Jaffer Ajani, Navtej Buttar, Amitabh Chak, Douglas Corley, Hashem El-Serag, Gary W. Falk, Rebecca Fitzgerald, John Goldblum, Frank Gress, David H. Ilson, John M. Inadomi, Ernest J. Kuipers, John P. Lynch, Frank McKeon, David Metz, Pankaj J. Pasricha, Oliver PechRichard Peek, Jeffrey H. Peters, Alessandro Repici, Stefan Seewald, Nicholas J. Shaheen, Rhonda F. Souza, Stuart J. Spechler, Prashanth Vennalaganti, Kenneth Wang

Research output: Contribution to journalArticlepeer-review

Abstract

The development of and adherence to quality indicators in gastroenterology, as in all of medicine, is increasing in importance to ensure that patients receive consistent high-quality care. In addition, government-based and private insurers will be expecting documentation of the parameters by which we measure quality, which will likely affect reimbursements. Barrett's esophagus remains a particularly important disease entity for which we should maintain up-to-date guidelines, given its commonality, potentially lethal outcomes, and controversies regarding screening and surveillance. To achieve this goal, a relatively large group of international experts was assembled and, using the modified Delphi method, evaluated the validity of multiple candidate quality indicators for the diagnosis and management of Barrett's esophagus. Several candidate quality indicators achieved >80% agreement. These statements are intended to serve as a consensus on candidate quality indicators for those who treat patients with Barrett's esophagus.

Original languageEnglish
Pages (from-to)1599-1606
Number of pages8
JournalGastroenterology
Volume149
Issue number6
DOIs
Publication statusPublished - Nov 1 2015

Keywords

  • Barrett's Esophagus
  • Barrett's Surveillance
  • Consensus Statements
  • Endoscopic Mucosal Resection
  • Esophageal Adenocarcinoma
  • Gastroesophageal Reflux Disease
  • High-Grade Dysplasia
  • Low-Grade Dysplasia
  • Metastatic Esophageal Adenocarcinoma
  • Prague Criteria
  • Proton Pump Inhibitors
  • Quality Indicators
  • Radiofrequency Ablation

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Quality Indicators for the Management of Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma: International Consensus Recommendations from the American Gastroenterological Association Symposium'. Together they form a unique fingerprint.

Cite this